Skip Navigation

Cardiovascular Research 1999 41(2):450-457; doi:10.1016/S0008-6363(98)00306-X
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Knight, C.G.
Right arrow Articles by Barnes, M. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knight, C.G.
Right arrow Articles by Barnes, M. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Collagen–platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen1

C.Graham Knighta, Laurence F Mortona, David J Onleya, Anthony R Peacheya, Tatsuo Ichinoheb,2, Minoru Okumab,3, Richard W Farndalea and Michael J Barnesa,*

aBiochemistry Department, Cambridge University, Cambridge, UK
bDepartment of Haematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

* Corresponding author. Tel.: +44-1223-766-089: fax: +44-1223-333-345.

Objective: Peptides consisting of a repeat Gly-Pro-Hyp sequence are potent platelet agonists. The aim of this study was: (1) to examine the specificity of this sequence for platelet activation; (2) to confirm its recognition by platelet glycoprotein VI; and (3) to assess with suitable peptides the relative importance of glycoprotein VI and integrin {alpha}2β1 in platelet activation by collagen. Methods: Peptides were synthesized by standard Fmoc chemistry and tested for their ability to support adhesion of human platelets and HT 1080 cells, induce platelet aggregation, bind integrin {alpha}2 subunit A-domain and to cause tyrosine phosphorylation of platelet proteins. Results: (1) Peptides consisting of a repeat Gly-Pro-Pro, Gly-Pro-Ala or Gly-Pro-Arg sequence exhibited little if any platelet-reactivity. (2) The platelet-reactive peptide consisting of a repeating Gly-Pro-Hyp sequence failed to induce tyrosine phosphorylation in glycoprotein VI-deficient platelets. Platelet adhesion to this peptide was inhibited by intact anti-glycoprotein VI antibody and its Fab fragment. The latter inhibited aggregation by the peptide and fibres of both collagens I and III. (3) A peptide containing a 15-mer {alpha}2β1-binding sequence in a repeat Gly-Pro-Pro structure supported {alpha}2β1-mediated platelet and HT 1080 cell adhesion and bound {alpha}2 A-domain, but failed to activate platelets or to induce tyrosine phosphorylation. Conversely, a peptide containing this sequence but with an essential Glu replaced by Ala and inserted in a repeat Gly-Pro-Hyp structure did not recognize {alpha}2β1, but was highly platelet activatory. Conclusions: Platelet activation by collagen involves the highly-specific recognition of the Gly-Pro-Hyp sequence by platelet glycoprotein VI. Recognition of {alpha}2β1 is insufficient to cause activation. Interaction between collagen and glycoprotein VI is unique since Gly-Pro-Hyp is common in collagens but occurs rarely in other proteins, and glycoprotein VI may be expressed solely by platelets. This sequence could provide a basis for a highly-specific anti-thrombotic reagent to control thrombosis associated with plaque rupture.

KEYWORDS Human platelets; Thrombosis; Collagens; Collagen-based peptides; Integrin {alpha}2β1; Glycoprotein VI


1 Amino acid sequences are defined using single-letter nomenclature (P*=Hyp); Ahx, 6-aminohexanoic acid; BSA, bovine serum albumin; CRP, collagen-related peptide; Fmoc, fluoren-9-ylmethoxycarbonyl; Gp, glycoprotein; mAb, monoclonal antibody; peptide-XL, crosslinked peptide; PRP, platelet-rich plasma.

2 Present address: Division of Hematology, Shizuoka General Hospital, 4-27-1 Kitaando, Shizuoka 420-0881, Japan.

3 Present address: Takashima General Hospital, 1667 Katsuno,Takashima-cho, Shiga-ken 520-1121, Japan.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Tang, S. Narayanan, G. Peruzzi, A. Apara, K. Natarajan, D. H. Margulies, J. E. Coligan, and F. Borrego
A Single Residue, Arginine 65, Is Critical for the Functional Interaction of Leukocyte-Associated Inhibitory Receptor-1 with Collagens
J. Immunol., May 1, 2009; 182(9): 5446 - 5452.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kato-Takagaki, Y. Mizukoshi, Y. Yoshizawa, D. Akazawa, Y. Torii, K. Ono, R. Tanimura, I. Shimada, and H. Takahashi
Structural and Interaction Analysis of Glycoprotein VI-binding Peptide Selected from a Phage Display Library
J. Biol. Chem., April 17, 2009; 284(16): 10720 - 10727.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. Cejas, W. A. Kinney, C. Chen, J. G. Vinter, H. R. Almond Jr., K. M. Balss, C. A. Maryanoff, U. Schmidt, M. Breslav, A. Mahan, et al.
Thrombogenic collagen-mimetic peptides: Self-assembly of triple helix-based fibrils driven by hydrophobic interactions
PNAS, June 24, 2008; 105(25): 8513 - 8518.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. E. Jarvis, N. Raynal, J. P. Langford, D. J. Onley, A. Andrews, P. A. Smethurst, and R. W. Farndale
Identification of a major GpVI-binding locus in human type III collagen
Blood, May 15, 2008; 111(10): 4986 - 4996.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.